
Raymond J. Henley Iii
Examiner (ID: 7179, Phone: (571)272-0575 , Office: P/1629 )
| Most Active Art Unit | 1614 |
| Art Unit(s) | 1205, 2899, 1629, 1614, 1621 |
| Total Applications | 4324 |
| Issued Applications | 3034 |
| Pending Applications | 603 |
| Abandoned Applications | 710 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 7061783
[patent_doc_number] => 20050004145
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-01-06
[patent_title] => 'Method of improved diuresis in individuals with impaired renal function'
[patent_app_type] => utility
[patent_app_number] => 10/830617
[patent_app_country] => US
[patent_app_date] => 2004-04-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 8069
[patent_no_of_claims] => 25
[patent_no_of_ind_claims] => 7
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0004/20050004145.pdf
[firstpage_image] =>[orig_patent_app_number] => 10830617
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/830617 | Method of improved diuresis in individuals with impaired renal function | Apr 22, 2004 | Issued |
Array
(
[id] => 7466103
[patent_doc_number] => 20040198668
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-10-07
[patent_title] => 'Method for treating obesity'
[patent_app_type] => new
[patent_app_number] => 10/830071
[patent_app_country] => US
[patent_app_date] => 2004-04-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 5470
[patent_no_of_claims] => 43
[patent_no_of_ind_claims] => 7
[patent_words_short_claim] => 23
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0198/20040198668.pdf
[firstpage_image] =>[orig_patent_app_number] => 10830071
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/830071 | Method for treating obesity | Apr 22, 2004 | Issued |
Array
(
[id] => 5253992
[patent_doc_number] => 20070135448
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2007-06-14
[patent_title] => 'Use of cathepsin k inhibitors for treating of severe bone loss diseases'
[patent_app_type] => utility
[patent_app_number] => 10/578167
[patent_app_country] => US
[patent_app_date] => 2004-04-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 5
[patent_no_of_words] => 9787
[patent_no_of_claims] => 12
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0135/20070135448.pdf
[firstpage_image] =>[orig_patent_app_number] => 10578167
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/578167 | Use of cathepsin k inhibitors for treating of severe bone loss diseases | Apr 18, 2004 | Abandoned |
Array
(
[id] => 7448616
[patent_doc_number] => 20040186158
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-09-23
[patent_title] => 'Novel composition of carvedilol'
[patent_app_type] => new
[patent_app_number] => 10/491195
[patent_app_country] => US
[patent_app_date] => 2004-03-31
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 1036
[patent_no_of_claims] => 6
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 9
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0186/20040186158.pdf
[firstpage_image] =>[orig_patent_app_number] => 10491195
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/491195 | Novel composition of carvedilol | Mar 30, 2004 | Abandoned |
Array
(
[id] => 830222
[patent_doc_number] => 07399776
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2008-07-15
[patent_title] => 'Polyamine compounds for treating chemokine receptor mediated diseases'
[patent_app_type] => utility
[patent_app_number] => 10/814058
[patent_app_country] => US
[patent_app_date] => 2004-03-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 13344
[patent_no_of_claims] => 6
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 6
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/399/07399776.pdf
[firstpage_image] =>[orig_patent_app_number] => 10814058
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/814058 | Polyamine compounds for treating chemokine receptor mediated diseases | Mar 29, 2004 | Issued |
Array
(
[id] => 7423148
[patent_doc_number] => 20040265312
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-12-30
[patent_title] => 'Methods for alleviating symptoms associated with neuropathic conditions comprising administration of low levels of antibodies'
[patent_app_type] => new
[patent_app_number] => 10/813661
[patent_app_country] => US
[patent_app_date] => 2004-03-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 7969
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 25
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0265/20040265312.pdf
[firstpage_image] =>[orig_patent_app_number] => 10813661
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/813661 | Methods for alleviating symptoms associated with neuropathic conditions comprising administration of low levels of antibodies | Mar 29, 2004 | Abandoned |
Array
(
[id] => 7428035
[patent_doc_number] => 20040229947
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-11-18
[patent_title] => 'Method of treating hyperactive bladder using phenoxyacetic acid derivatives'
[patent_app_type] => new
[patent_app_number] => 10/809346
[patent_app_country] => US
[patent_app_date] => 2004-03-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 5
[patent_no_of_words] => 4487
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 27
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0229/20040229947.pdf
[firstpage_image] =>[orig_patent_app_number] => 10809346
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/809346 | Method of treating hyperactive bladder using phenoxyacetic acid derivatives | Mar 25, 2004 | Abandoned |
Array
(
[id] => 6906227
[patent_doc_number] => 20050101622
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-05-12
[patent_title] => 'Method and composition for treating irritable bowel syndrome using low doses of opioid receptor antagonists'
[patent_app_type] => utility
[patent_app_number] => 10/807508
[patent_app_country] => US
[patent_app_date] => 2004-03-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5189
[patent_no_of_claims] => 28
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0101/20050101622.pdf
[firstpage_image] =>[orig_patent_app_number] => 10807508
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/807508 | Method and composition for treating irritable bowel syndrome using low doses of opioid receptor antagonists | Mar 22, 2004 | Abandoned |
Array
(
[id] => 7418354
[patent_doc_number] => 20040182704
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-09-23
[patent_title] => 'Artificial muscle hydrogel blends reversibly electroactuated near neutral pH, implantable actuating devices, and methods using the same'
[patent_app_type] => new
[patent_app_number] => 10/803985
[patent_app_country] => US
[patent_app_date] => 2004-03-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 13
[patent_figures_cnt] => 13
[patent_no_of_words] => 9030
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 75
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0182/20040182704.pdf
[firstpage_image] =>[orig_patent_app_number] => 10803985
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/803985 | Artificial muscle hydrogel blends reversibly electroactuated near neutral pH, implantable actuating devices, and methods using the same | Mar 18, 2004 | Issued |
Array
(
[id] => 919733
[patent_doc_number] => 07320961
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2008-01-22
[patent_title] => 'Method for treating a disease, disorder or adverse effect caused by an elevated serum concentration of an UGT1A1 substrate'
[patent_app_type] => utility
[patent_app_number] => 10/802829
[patent_app_country] => US
[patent_app_date] => 2004-03-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 6
[patent_no_of_words] => 6520
[patent_no_of_claims] => 11
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 34
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/320/07320961.pdf
[firstpage_image] =>[orig_patent_app_number] => 10802829
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/802829 | Method for treating a disease, disorder or adverse effect caused by an elevated serum concentration of an UGT1A1 substrate | Mar 17, 2004 | Issued |
Array
(
[id] => 418864
[patent_doc_number] => 07276536
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2007-10-02
[patent_title] => 'Method for increasing the bioavailability of the active form of S-[2-([[1-(2-ethylbutyl)cyclohexyl]carbonyl]amino) phenyl] 2-methylpropanethioate'
[patent_app_type] => utility
[patent_app_number] => 10/802280
[patent_app_country] => US
[patent_app_date] => 2004-03-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 5
[patent_no_of_words] => 6766
[patent_no_of_claims] => 70
[patent_no_of_ind_claims] => 7
[patent_words_short_claim] => 57
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/276/07276536.pdf
[firstpage_image] =>[orig_patent_app_number] => 10802280
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/802280 | Method for increasing the bioavailability of the active form of S-[2-([[1-(2-ethylbutyl)cyclohexyl]carbonyl]amino) phenyl] 2-methylpropanethioate | Mar 16, 2004 | Issued |
Array
(
[id] => 6939788
[patent_doc_number] => 20050113351
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-05-26
[patent_title] => 'Prevention of ovarian cancer by administration of products that induce biologic effects in the ovarian epithelium'
[patent_app_type] => utility
[patent_app_number] => 10/802427
[patent_app_country] => US
[patent_app_date] => 2004-03-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 40575
[patent_no_of_claims] => 1
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0113/20050113351.pdf
[firstpage_image] =>[orig_patent_app_number] => 10802427
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/802427 | Prevention of ovarian cancer by administration of products that induce biologic effects in the ovarian epithelium | Mar 16, 2004 | Abandoned |
Array
(
[id] => 7446757
[patent_doc_number] => 20040186049
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-09-23
[patent_title] => 'Inhibition of histone deacetylase as a treatment for cardiac hypertrophy'
[patent_app_type] => new
[patent_app_number] => 10/801985
[patent_app_country] => US
[patent_app_date] => 2004-03-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 7
[patent_no_of_words] => 12886
[patent_no_of_claims] => 50
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 30
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0186/20040186049.pdf
[firstpage_image] =>[orig_patent_app_number] => 10801985
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/801985 | Inhibition of histone deacetylase as a treatment for cardiac hypertrophy | Mar 15, 2004 | Issued |
Array
(
[id] => 7410284
[patent_doc_number] => 20040176354
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-09-09
[patent_title] => 'Treatment of congestive heart failure'
[patent_app_type] => new
[patent_app_number] => 10/799415
[patent_app_country] => US
[patent_app_date] => 2004-03-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 7261
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 20
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0176/20040176354.pdf
[firstpage_image] =>[orig_patent_app_number] => 10799415
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/799415 | Treatment of congestive heart failure | Mar 11, 2004 | Abandoned |
Array
(
[id] => 7410694
[patent_doc_number] => 20040176387
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-09-09
[patent_title] => 'Method of treating peripheral vascular diseases, peripheral neuropathies, and autonomic neuropathies'
[patent_app_type] => new
[patent_app_number] => 10/798135
[patent_app_country] => US
[patent_app_date] => 2004-03-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 3435
[patent_no_of_claims] => 7
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 26
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0176/20040176387.pdf
[firstpage_image] =>[orig_patent_app_number] => 10798135
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/798135 | Method of treating peripheral vascular diseases, peripheral neuropathies, and autonomic neuropathies | Mar 9, 2004 | Abandoned |
Array
(
[id] => 7423935
[patent_doc_number] => 20040265401
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-12-30
[patent_title] => 'Chemical composition for aiding the absorption, binding and elimination of undigested fat'
[patent_app_type] => new
[patent_app_number] => 10/796561
[patent_app_country] => US
[patent_app_date] => 2004-03-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4351
[patent_no_of_claims] => 30
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 82
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0265/20040265401.pdf
[firstpage_image] =>[orig_patent_app_number] => 10796561
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/796561 | Chemical composition for aiding the absorption, binding and elimination of undigested fat | Mar 8, 2004 | Abandoned |
Array
(
[id] => 6945353
[patent_doc_number] => 20050197402
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-09-08
[patent_title] => 'Dietary supplementation with stoichiometrically specific potassium magnesium citrate'
[patent_app_type] => utility
[patent_app_number] => 10/797321
[patent_app_country] => US
[patent_app_date] => 2004-03-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 16
[patent_figures_cnt] => 16
[patent_no_of_words] => 7254
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0197/20050197402.pdf
[firstpage_image] =>[orig_patent_app_number] => 10797321
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/797321 | Dietary supplementation with stoichiometrically specific potassium magnesium citrate | Mar 7, 2004 | Issued |
Array
(
[id] => 7151015
[patent_doc_number] => 20040171593
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-09-02
[patent_title] => 'Method and compositions for treating an inflammatory disease'
[patent_app_type] => new
[patent_app_number] => 10/796658
[patent_app_country] => US
[patent_app_date] => 2004-03-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 3480
[patent_no_of_claims] => 2
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 53
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0171/20040171593.pdf
[firstpage_image] =>[orig_patent_app_number] => 10796658
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/796658 | Method and compositions for treating an inflammatory disease | Mar 7, 2004 | Abandoned |
Array
(
[id] => 820342
[patent_doc_number] => 07407671
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2008-08-05
[patent_title] => 'Temperature controlled solute delivery system'
[patent_app_type] => utility
[patent_app_number] => 10/787233
[patent_app_country] => US
[patent_app_date] => 2004-02-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 11
[patent_figures_cnt] => 24
[patent_no_of_words] => 9671
[patent_no_of_claims] => 12
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 95
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/407/07407671.pdf
[firstpage_image] =>[orig_patent_app_number] => 10787233
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/787233 | Temperature controlled solute delivery system | Feb 26, 2004 | Issued |
Array
(
[id] => 803328
[patent_doc_number] => 07423032
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2008-09-09
[patent_title] => 'Method for treating severe heart failure and medicament therefor'
[patent_app_type] => utility
[patent_app_number] => 10/523020
[patent_app_country] => US
[patent_app_date] => 2004-02-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5849
[patent_no_of_claims] => 4
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 64
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/423/07423032.pdf
[firstpage_image] =>[orig_patent_app_number] => 10523020
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/523020 | Method for treating severe heart failure and medicament therefor | Feb 22, 2004 | Issued |